White matter changes in the perforant path area in patients with amyotrophic lateral sclerosis

White matter changes in the perforant path area in patients with amyotrophic lateral sclerosis

<p><strong>OBJECTIVE:</strong> The aim of this study was to test the hypothesis that white matter degeneration of the perforant path - as part of the Papez circuit - is a key feature of amyotrophic lateral sclerosis (ALS), even in the absence of frontotemporal dementia (FTD) or dep...

Full description

Bibliographic Details
Main Authors:	Mollink, J, Hiemstra, M, Miller, K, Huszar, I, Jenkinson, M, Raaphorst, J, Wiesmann, M, Ansorge, O, Pallebage-Gamarallage, M, Van Cappellen Van Walsum, A
Format:	Journal article
Language:	English
Published:	Wiley 2019

Similar Items

Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology
by: Pallebage-Gamarallage, M, et al.
Published: (2018)

Methods for quantitative susceptibility and R2* mapping in whole post-mortem brains at 7T applied to amyotrophic lateral sclerosis
by: Wang, C, et al.
Published: (2020)

Evaluating fibre orientation dispersion in white matter: Comparison of diffusion MRI, histology and polarized light imaging.
by: Mollink, J, et al.
Published: (2017)

Methods for quantitative susceptibility and R2* mapping in whole post-mortem brains at 7T applied to amyotrophic lateral sclerosis
by: Chaoyue Wang, et al.
Published: (2020-11-01)

Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology
by: Menuka Pallebage-Gamarallage, et al.
Published: (2018-03-01)

Diffusion MRI fibre orientation dispersion estimates evaluated with polarized light imaging and histological analysis
by: Mollink, J, et al.
Published: (2017)

Evaluating fibre orientation dispersion in white matter: Comparison of diffusion MRI, histology and polarized light imaging
by: Jeroen Mollink, et al.
Published: (2017-08-01)

Amyotrophic lateral sclerosis: the complex path to precision medicine
by: Talbot, K, et al.
Published: (2018)

No association between gluten sensitivity and amyotrophic lateral sclerosis
by: Visser, A, et al.
Published: (2017)

Combining digital histology with magnetic resonance imaging in amyotrophic lateral sclerosis
by: Huszar, IN
Published: (2020)

Quantitative FLAIR MRI in amyotrophic lateral sclerosis
by: Fabes, J, et al.
Published: (2017)

Concurrent multiple sclerosis and amyotrophic lateral sclerosis: where inflammation and neurodegeneration meet?
by: Li, G, et al.
Published: (2012)

Amyotrophic lateral sclerosis.
by: Kiernan, M, et al.
Published: (2011)

Concurrent multiple sclerosis and amyotrophic lateral sclerosis: where inflammation and neurodegeneration meet?
by: Li Grace, et al.
Published: (2012-01-01)

The spatial correspondence and genetic influence of interhemispheric connectivity with white matter microstructure
by: Mollink, J, et al.
Published: (2019)

The spatial correspondence and genetic influence of interhemispheric connectivity with white matter microstructure
by: Mollink, J, et al.
Published: (2019)

Controversies and priorities in amyotrophic lateral sclerosis.
by: Turner, M, et al.
Published: (2013)

Multicenter evaluation of neurofilaments in early symptomatic amyotrophic lateral sclerosis
by: Feneberg, E, et al.
Published: (2017)

The reunification of amyotrophic lateral sclerosis
by: Turner, M
Published: (2018)

Biomarkers in amyotrophic lateral sclerosis.
by: Turner, M, et al.
Published: (2009)

Neuroimaging endpoints in amyotrophic lateral sclerosis
by: Menke, R, et al.
Published: (2016)

The genetics of amyotrophic lateral sclerosis
by: Schymick, J
Published: (2009)

Neuroimaging in amyotrophic lateral sclerosis.
by: Turner, M, et al.
Published: (2012)

Amyotrophic lateral sclerosis
by: Leigh P Nigel, et al.
Published: (2009-02-01)

Evolution of white matter damage in amyotrophic lateral sclerosis
by: Gabel, M, et al.
Published: (2020)

Towards a neuroimaging biomarker for amyotrophic lateral sclerosis.
by: Turner, M, et al.
Published: (2011)

Defining pre-symptomatic amyotrophic lateral sclerosis
by: Benatar, M, et al.
Published: (2019)

An automated pipeline for extracting histological stain area fraction for voxelwise quantitative MRI-histology comparisons
by: Kor, DZL, et al.
Published: (2022)

Modelling amyotrophic lateral sclerosis: progress and possibilities
by: Philip Van Damme, et al.
Published: (2017-05-01)

Gene therapy for amyotrophic lateral sclerosis
by: Thais Federici, et al.
Published: (2012-11-01)

Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.
by: Bowser, R, et al.
Published: (2011)

Deontological aspects of the amyotrophic lateral sclerosis
by: T. M. Alekseeva, et al.
Published: (2018-01-01)

Potential Preventive Strategies for Amyotrophic Lateral Sclerosis
by: B. Kuraszkiewicz, et al.
Published: (2020-05-01)

Animal Models Of Amyotrophic Lateral Sclerosis
by: Raju Trichur. R, et al.
Published: (1999-01-01)

Quantifying disease progression in amyotrophic lateral sclerosis.
by: Simon, N, et al.
Published: (2014)

Defective cholesterol metabolism in amyotrophic lateral sclerosis.
by: Abdel-Khalik, J, et al.
Published: (2016)

Abnormal RNA stability in amyotrophic lateral sclerosis
by: E. M. Tank, et al.
Published: (2018-07-01)

Juvenile Familial Amyotrophic Lateral Sclerosis
by: J Gordon Millichap
Published: (1998-07-01)

Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease.
by: Talbot, K, et al.
Published: (2006)

Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
by: Siobhan E. Kirk, et al.
Published: (2019-03-01)